SQUADRA AVOCATS ASSISTED AMPHASTAR FRANCE PHARMACEUTICALS IN CONNECTION WITH THE REFINANCING AND CLOSING BY ITS US PARENT COMPANY AMPHASTAR PHARMACEUTICALS OF A USD 140 MILLION LOAN WITH A BANKING SYNDICATE LED BY CAPITAL ONE BANK, NATIONAL ASSOCIATION
Amphastar Pharmaceuticals is a biopharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. Amphastar France Pharmaceuticals […]